Ergocalciferol, also known as Vitamin D2, is a fat-soluble vitamin that plays a crucial role in maintaining bone health and calcium homeostasis in the body. It is often found under various trade names such as Drisdol and Calciferol. Unlike its counterpart,
Vitamin D3 (cholecalciferol), which is derived from animal sources, Ergocalciferol is primarily obtained from plant sources and yeast. This makes it particularly valuable for individuals who follow a vegetarian or vegan diet. Ergocalciferol is used to treat or prevent conditions resulting from low levels of Vitamin D, such as
rickets or
osteomalacia. The drug targets
Vitamin D receptors in various tissues, helping to improve calcium and phosphate absorption in the intestines, thus promoting bone mineralization. Research institutions and pharmaceutical companies continue to investigate the broader applications of Ergocalciferol, including its potential role in immune function and
chronic disease prevention.
The mechanism of action of Ergocalciferol is relatively straightforward yet profoundly impactful. Once ingested, Ergocalciferol is converted in the liver to 25-hydroxyvitamin D2 (calcidiol). This metabolite is then further hydroxylated in the kidneys to form 1,25-dihydroxyvitamin D2 (
calcitriol), the active form of Vitamin D2. Calcitriol functions as a hormone, binding to Vitamin D receptors (VDR) in various organs, including the intestines, bones, and kidneys. By binding to these receptors, calcitriol facilitates the absorption of calcium and phosphate from the gastrointestinal tract, thus maintaining proper serum calcium and phosphate levels. This process is essential for the formation and maintenance of healthy bone structure. Additionally, Ergocalciferol modulates immune function and has been implicated in the regulation of cell growth and differentiation, which is an area of ongoing research.
Ergocalciferol can be administered in several forms, including oral tablets, capsules, and liquid solutions. The drug is also available as an intramuscular injection for individuals who may have difficulty absorbing it through the gastrointestinal tract. The onset of action for oral Ergocalciferol typically occurs within a few days to a week, depending on the severity of the deficiency being treated and the dosage administered. It's crucial to follow the prescribed dosage and administration guidelines provided by a healthcare provider to ensure optimal absorption and effectiveness. For most individuals, Ergocalciferol is taken once daily or weekly, depending on the specific condition being treated. It is often recommended to take the supplement with a meal containing fat to enhance its absorption, as Vitamin D2 is fat-soluble. Periodic blood tests may be necessary to monitor
Vitamin D levels and adjust the dosage as needed.
Although Ergocalciferol is generally well-tolerated, it can cause side effects, particularly if taken in excessive amounts. Common side effects include gastrointestinal issues such as
nausea,
vomiting,
constipation, or
diarrhea. More serious side effects can occur with prolonged high doses, including
hypercalcemia (elevated calcium levels in the blood), which can lead to symptoms such as
confusion,
weakness,
fatigue, and
irregular heart rhythms. In severe cases, hypercalcemia can cause
kidney stones or even
kidney failure. Therefore, it is essential to adhere to the prescribed dosage and not to self-medicate with over-the-counter supplements without consulting a healthcare provider. Contraindications for Ergocalciferol use include conditions like hypercalcemia,
malabsorption syndromes, and known hypersensitivity to Vitamin D or its components. Patients with
chronic kidney disease should use Ergocalciferol cautiously, as their ability to convert it to its active form may be impaired. Pregnant and breastfeeding women should consult their healthcare provider before starting Ergocalciferol to avoid potential risks to the fetus or infant.
Drug interactions can affect the efficacy of Ergocalciferol and may lead to adverse effects. For instance, certain medications can reduce the absorption or increase the metabolism of Ergocalciferol, thereby diminishing its effectiveness. These medications include anticonvulsants like
phenytoin and
phenobarbital, which induce liver enzymes that metabolize Vitamin D. Similarly, corticosteroids can interfere with Vitamin D metabolism and calcium absorption, potentially exacerbating bone health issues.
Cholestyramine and other bile acid sequestrants can also reduce the absorption of fat-soluble vitamins, including Ergocalciferol. On the other hand, medications that affect kidney function, such as thiazide diuretics, can increase the risk of hypercalcemia when taken with Ergocalciferol. It is crucial to inform your healthcare provider of all medications, supplements, and herbal products you are taking to avoid potential interactions.
In summary, Ergocalciferol is a valuable medication for managing and preventing
Vitamin D deficiency and its associated conditions. By understanding its mechanism of action, proper administration methods, potential side effects, and drug interactions, patients can use Ergocalciferol safely and effectively under the guidance of their healthcare provider. Ongoing research continues to uncover the broader implications of Vitamin D2 in human health, promising new therapeutic avenues in the future.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


